These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


761 related items for PubMed ID: 19486265

  • 1. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
    Hajieva P, Mocko JB, Moosmann B, Behl C.
    J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
    [Abstract] [Full Text] [Related]

  • 2. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
    Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, Li W, Liu J.
    J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
    [Abstract] [Full Text] [Related]

  • 3. Protective activity of aromatic amines and imines against oxidative nerve cell death.
    Moosmann B, Skutella T, Beyer K, Behl C.
    Biol Chem; 2001 Nov; 382(11):1601-12. PubMed ID: 11767950
    [Abstract] [Full Text] [Related]

  • 4. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [Abstract] [Full Text] [Related]

  • 5. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R, Nehru B.
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [Abstract] [Full Text] [Related]

  • 6. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
    Fernandez-Gomez FJ, Pastor MD, Garcia-Martinez EM, Melero-Fernandez de Mera R, Gou-Fabregas M, Gomez-Lazaro M, Calvo S, Soler RM, Galindo MF, Jordán J.
    Neurobiol Dis; 2006 Nov; 24(2):296-307. PubMed ID: 16978869
    [Abstract] [Full Text] [Related]

  • 7. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.
    Leak RK, Liou AK, Zigmond MJ.
    J Neurochem; 2006 Nov; 99(4):1151-63. PubMed ID: 16956375
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
    Moon Y, Lee KH, Park JH, Geum D, Kim K.
    J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
    [Abstract] [Full Text] [Related]

  • 10. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ, Rauhala P, Tuominen RK, Liesi P.
    J Neurosci Res; 2006 Aug 15; 84(3):655-65. PubMed ID: 16810683
    [Abstract] [Full Text] [Related]

  • 11. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM, Sherer TB, Greenamyre JT.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):109-18. PubMed ID: 15790535
    [Abstract] [Full Text] [Related]

  • 12. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D, Pérez-De La Cruz V, Herrera-Mundo MN, Mendoza-Macedo K, Villeda-Hernández J, Binienda Z, Ali SF, Santamaría A.
    J Neurochem; 2008 May 24; 105(3):677-89. PubMed ID: 18194214
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
    Chinta SJ, Andersen JK.
    Free Radic Biol Med; 2006 Nov 01; 41(9):1442-8. PubMed ID: 17023271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway.
    Chen H, Wang S, Ding JH, Hu G.
    J Neurochem; 2008 Sep 01; 106(6):2345-52. PubMed ID: 18643790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells.
    Lu XL, Yao XL, Liu Z, Zhang H, Li W, Li Z, Wang GL, Pang J, Lin Y, Xu Z, Chen L, Pei Z, Zeng J.
    Brain Res; 2010 May 21; 1332():110-9. PubMed ID: 20347725
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.